Login / Signup

Achieving remission of proteinuria in childhood CKD.

Piero RuggenentiPaolo CravediAntonietta ChiancaMariaRosa CarusoGuiseppe Remuzzi
Published in: Pediatric nephrology (Berlin, Germany) (2016)
Combination therapy with maximum approved doses of ACE inhibitors and ARBs is a safe strategy which may achieve proteinuria remission with kidney function stabilization or even improvement in a substantial proportion of children with proteinuric nephropathies.
Keyphrases
  • combination therapy
  • disease activity
  • ulcerative colitis
  • chronic kidney disease
  • young adults
  • angiotensin ii
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • early life